Department of Pathology and Cell Biology, Columbia University-Irving Medical Center, New York, NY, USA.
Pediatr Dev Pathol. 2023 Mar-Apr;26(2):166-171. doi: 10.1177/10935266231152370. Epub 2023 Feb 12.
Papillary intralymphatic angioendothelioma (PILA) is an extremely rare vascular tumor and its pathogenesis is unknown. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum (PROS) is a heterogeneous group of disorders caused by mosaicism for activating mutations of and characterized by asymmetric overgrowth, skeletal anomalies, skin lesions, and vascular malformations. An association between PILA and PROS has not been known. We report a case of PILA involving the spleen of a young girl with the clinical and molecular diagnosis of PROS. Sequencing of the patient's germ-line DNA detected a pathogenic variant c.1357G>A in 10.6% of alleles. Splenectomy revealed a 4-cm tumor composed of ectatic lymphatics with intraluminal papillary projections, consistent with PILA. The tumor cells showed immunohistochemical expression of CD31, CD34, ERG, FLI-1, PROX1, and caldesmon, while D2-40 was negative. The latter may suggest that the tumor derived from an endothelial precursor arrested in the final steps of lymphothelial differentiation, in keeping with the known role of the -governed molecular pathway in the progression of vascular progenitors to mature endothelial cells. The data implicates in the pathogenesis of PILA and broadens the spectrum of phenotypic expressions of PROS.
乳头状淋巴管内血管内皮细胞瘤 (PILA) 是一种极其罕见的血管肿瘤,其发病机制尚不清楚。磷脂酰肌醇-4,5-二磷酸 3-激酶催化亚单位 α (PIK3CA) 相关过度生长谱 (PROS) 是一组由 和 激活突变镶嵌引起的异质性疾病,其特征为不对称性过度生长、骨骼异常、皮肤损伤和血管畸形。目前尚不知道 PILA 与 PROS 之间存在关联。我们报告了一例涉及年轻女孩脾脏的 PILA 病例,该患者具有 PROS 的临床和分子诊断。对患者的种系 DNA 进行测序,在 10.6%的等位基因中检测到致病性 变体 c.1357G>A。脾切除术显示一个 4 厘米大的肿瘤,由扩张的淋巴管组成,管腔内有乳头状突起,符合 PILA 的表现。肿瘤细胞表现出 CD31、CD34、ERG、FLI-1、PROX1 和钙调蛋白的免疫组化表达,而 D2-40 为阴性。后者可能表明肿瘤来源于一个内皮前体细胞,其在淋巴内皮分化的最后步骤中停滞不前,这与 调控的分子途径在血管祖细胞向成熟内皮细胞的进展中的作用是一致的。这些数据提示 在 PILA 的发病机制中起作用,并拓宽了 PROS 的表型表达谱。